A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Clinical trial NCT05589896 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05589896
Sponsor: Ossium Health, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Biphenotypic Leukemia Acute Undifferentiated Leukemia CLL (Chronic Lymphocytic Leukemia)Chronic Myeloid Leukemia (CML)MDS (Myelodysplastic Syndrome)Non-Hodgkin Lymphomas Hodgkins Lymphoma Cutaneous T Cell Lymphomas (CTCL)

Start date: 2024-08-16
Primary completion: 2026-07-14
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.